Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
animal testing
Biotech
FDA, NIH pledge flexibility and $150M for animal alternatives
Draft guidance from the CDER invites applicants to provide data from animal testing alternatives even if they haven't been validated by the agency.
Darren Incorvaia
Mar 18, 2026 9:00am
Charles River's incoming CEO talks R&D processes, reorg goals
Jan 28, 2026 12:58pm
Charles River inks $510M deal to bring primate supply in-house
Jan 14, 2026 10:45am
FDA issues plan to reduce primate testing for certain antibodies
Dec 2, 2025 11:25am
CDC orders researchers to end all monkey studies: Science
Nov 21, 2025 1:15pm
Charles River lays off 70 staffers as strategic shift begins
Nov 14, 2025 4:40pm
